Physician profile
Christopher J Salgado
NPI 1124100599
$35,094.30
in general payments reported to CMS, 2019-2025
29 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,674 · 2020: $560 · 2021: $1,804 · 2022: $19K · 2023: $7,695 · 2024: $1,653 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,039 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,175 · Travel and Lodging: $2,016 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,039.23 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,175.00 |
| Travel and Lodging | $2,016.32 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $23,183.94 | 2021-2025 | Celleraterx, Celleraterx |
| Allergan, INC. | $4,670.10 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $2,415.80 | 2021-2023 | |
| Abbvie INC. | $1,689.94 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $560.44 | 2020-2024 | Durasorb Monofilament Mesh, Integra, Omnigraft |
| Kerecis Limited | $359.64 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Axogen | $337.67 | 2021-2023 | Avance Nerve Graft |
| Stryker Corporation | $312.76 | 2021-2023 | Spy-Phi System |
| Polynovo North America LLC | $220.65 | 2024-2025 | Novosorb Btm |
| Next Science LLC | $214.28 | 2023-2024 | Surgx, Blastx, Xperience |
| Smith+Nephew, INC. | $186.27 | 2019-2025 | Renasys Touch |
| Sientra, INC. | $158.87 | 2022 | |
| Organogenesis INC. | $144.39 | 2021 | |
| Kci USA, INC. | $105.76 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Davol INC. | $84.29 | 2024 | Arista Ah Flexitip |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $73.93 | 2021 | |
| Biopro, INC. | $66.67 | 2019 | |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
| Pacira Pharmaceuticals Incorporated | $41.54 | 2025 | Exparel |
| Solventum Corporation | $35.90 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Acell, INC. | $30.86 | 2019 | |
| Innovation Technologies INC | $23.66 | 2021 | |
| Medela LLC | $23.21 | 2019 | |
| Amniox Medical, INC. | $22.00 | 2019 | |
| Motiva USA, LLC | $19.89 | 2025 | |
| Solta Medical, A Division of Bausch Health US, LLC | $19.44 | 2020 | |
| Coopersurgical, INC. | $16.84 | 2020 | |
| Mimedx Group, INC. | $13.61 | 2025 | |
| Acera Surgical, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Salgado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.